Cite
Inclisiran in individuals with diabetes or obesity: Post hoc pooled analyses of the ORION‐9, ORION‐10 and ORION‐11 Phase 3 randomized trials.
MLA
Leiter, Lawrence A., et al. “Inclisiran in Individuals with Diabetes or Obesity: Post Hoc Pooled Analyses of the ORION‐9, ORION‐10 and ORION‐11 Phase 3 Randomized Trials.” Diabetes, Obesity & Metabolism, vol. 26, no. 8, Aug. 2024, pp. 3223–37. EBSCOhost, https://doi.org/10.1111/dom.15650.
APA
Leiter, L. A., Raal, F. J., Schwartz, G. G., Koenig, W., Ray, K. K., Landmesser, U., Han, J., Conde, L. G., & Wright, R. S. (2024). Inclisiran in individuals with diabetes or obesity: Post hoc pooled analyses of the ORION‐9, ORION‐10 and ORION‐11 Phase 3 randomized trials. Diabetes, Obesity & Metabolism, 26(8), 3223–3237. https://doi.org/10.1111/dom.15650
Chicago
Leiter, Lawrence A., Frederick J. Raal, Gregory G. Schwartz, Wolfgang Koenig, Kausik K. Ray, Ulf Landmesser, Jackie Han, Lorena Garcia Conde, and R. Scott Wright. 2024. “Inclisiran in Individuals with Diabetes or Obesity: Post Hoc Pooled Analyses of the ORION‐9, ORION‐10 and ORION‐11 Phase 3 Randomized Trials.” Diabetes, Obesity & Metabolism 26 (8): 3223–37. doi:10.1111/dom.15650.